Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer

Clinical trial NCT04966676 · TERMINATED

Trial details

NCT number: NCT04966676
Sponsor: University Health Network, Toronto
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2022-01-24
Primary completion: 2025-02-19
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.